SPCC285.05 Antibody

What is SPCC285.05 and what is its biological function?

SPCC285.05 is an uncharacterized protein from the fission yeast Schizosaccharomyces pombe that functions as a probable nucleoside permease, specifically transporting adenosine and guanosine across cellular membranes . The protein consists of 348 amino acids with the functional domain spanning residues 22-348. Its transport function suggests it plays a role in nucleoside metabolism, which is critical for numerous cellular processes including DNA replication and RNA synthesis. Understanding this protein could provide insights into fundamental aspects of nucleoside transport mechanisms in eukaryotic cells.

What is the structure of SPCC285.05 and how does it influence antibody development?

The complete amino acid sequence of SPCC285.05 is known: GLIGKRSVFK PKVMIINMFS LEANAWLSQM DDLYANNITV VGLNRLYPQV HCNTQQTICQ MTTGEGKSNA ASSIMALTLS PKFDLTETFF LISGIAGINP YAASLGSVGV ARFAVDIDLI NSVDLRELPS YFQSSGWEID TDPYENGSSN EIVYPESMPY QTNLYELNNT LITAAMEIIK DVVLEDNEKA ASYRKLYNES AARRPPFITQ CDTATGDNYW AGTYMGDFVS NITNVLTNST GHYCTTQQED NASLTALTRA SFDGLVNINR VVIMRSGSDF DRGAGNITAL ANLLNSTGHV SSLACDNLYH AGAPLIDHIV NHWSYWT . While the tertiary structure has not been fully characterized, bioinformatic analysis suggests multiple transmembrane domains consistent with its role as a permease. When developing antibodies against SPCC285.05, researchers should target epitopes predicted to be in extracellular loops or accessible regions rather than transmembrane domains, which would improve antibody binding efficacy in various applications.

How can I determine the specificity of an anti-SPCC285.05 antibody?

To determine antibody specificity, implement a multi-approach validation strategy:

• Western blotting: Compare wild-type S. pombe lysates with SPCC285.05 knockout strains to confirm specific band detection at the expected molecular weight.

• Immunoprecipitation: Validate that the antibody can pull down SPCC285.05 from cell lysates, confirmed by mass spectrometry.

• Competitive binding assays: Pre-incubate the antibody with recombinant SPCC285.05 protein before application to demonstrate signal reduction.

• Cross-reactivity testing: Evaluate potential cross-reactivity with homologous proteins in S. pombe or other species by comparing sequence homology and experimental validation .

• Immunofluorescence: Compare localization patterns in wild-type and knockout strains to confirm membrane localization consistent with a permease.

This comprehensive validation approach ensures that experimental observations are genuinely attributed to SPCC285.05.

What are the optimal immunization strategies for generating SPCC285.05 antibodies?

For generating high-quality antibodies against SPCC285.05, consider these evidence-based immunization strategies:

• Antigen selection: Use either full-length recombinant SPCC285.05 (amino acids 22-348) or select peptides from predicted extracellular domains based on hydrophilicity and surface accessibility analysis .

• Host selection: While rabbits are commonly used, goats may provide higher antibody yields for membrane proteins like SPCC285.05, similar to strategies used for other transmembrane proteins .

• Adjuvant optimization: Complete Freund's adjuvant for initial immunization followed by incomplete Freund's for booster injections typically yields strong immune responses against yeast proteins.

• Immunization schedule: A primary injection followed by 3-4 booster immunizations at 2-3 week intervals typically generates high-titer antibodies.

• Screening approach: Implement a multi-tiered screening strategy using ELISA against the immunogen followed by validation in S. pombe lysates to identify antibodies that recognize the native protein conformation .

This systematic approach maximizes the likelihood of generating specific and high-affinity antibodies against SPCC285.05.

How can I optimize recombinant SPCC285.05 protein expression for antibody development?

Optimizing recombinant SPCC285.05 expression requires addressing several key parameters:

• Expression system selection:

  • For full-length protein: Baculovirus expression systems often yield properly folded transmembrane proteins

  • For specific domains: E. coli or yeast expression systems may be suitable for soluble domain fragments

• Construct design considerations:

  • Include affinity tags (His6 or GST) positioned to avoid interference with functional domains

  • Consider expressing specific domains (residues 22-348) rather than the complete sequence to improve solubility

  • Codon optimization for the selected expression system

• Expression optimization:

  Parameter	E. coli	Yeast	Baculovirus
  Temperature	16-30°C	25-30°C	27°C
  Induction	0.1-1.0 mM IPTG	0.5-2% methanol	MOI 1-10
  Duration	4-24 hours	24-72 hours	48-72 hours
  Yield (typical)	1-5 mg/L	2-10 mg/L	5-20 mg/L

• Purification strategy: For membrane proteins like SPCC285.05, detergent screening (DDM, CHAPS, OG) is crucial for maintaining native conformation during solubilization and purification .

• Quality control: Assess protein homogeneity by SEC-MALS and thermal stability using differential scanning fluorimetry before immunization to ensure optimal antigen quality .

What is the optimal protocol for immunoprecipitation of SPCC285.05 from S. pombe?

Based on successful protocols for yeast protein immunoprecipitation, here is an optimized method for SPCC285.05:

• Cell preparation:

  • Grow S. pombe cells to exponential phase (~5 × 10^6 cells/ml) at 30°C in appropriate medium

  • Harvest cells by centrifugation (3,500 rpm, 5 minutes, room temperature)

  • Wash twice with ice-cold 50 mM Tris-Cl pH 7.5

• Lysis and extraction:

  • Resuspend pellet in cell lysis buffer (250 mM NaCl, 20 mM Tris-Cl pH 7.5, 1% Triton-X100, 100 mM potassium acetate, with protease and phosphatase inhibitor cocktails)

  • Lyse cells using glass beads in a bead beater (8 cycles of 30 seconds with 1-minute cooling intervals)

  • Centrifuge at 14,000 × g for 15 minutes at 4°C to remove cell debris

• Immunoprecipitation:

  • Pre-clear lysate with Protein G beads for 1 hour at 4°C

  • Incubate cleared lysate with anti-SPCC285.05 antibody (5-10 μg) overnight at 4°C with gentle rotation

  • Add Protein G beads and incubate for 2-3 hours at 4°C

  • Wash beads 4-5 times with wash buffer (lysis buffer with reduced detergent concentration)

  • Elute bound proteins with SDS sample buffer or by gentle acid elution

• Analysis:

  • Analyze by SDS-PAGE followed by western blotting or mass spectrometry

  • For interaction studies, consider using cross-linking agents before lysis to stabilize transient interactions

This protocol has been adapted from successful approaches used for S. pombe protein studies and incorporates conditions specific for membrane protein extraction.

How can I use anti-SPCC285.05 antibodies to study protein-protein interactions?

Several approaches can be employed to study SPCC285.05 protein-protein interactions using antibodies:

• Co-immunoprecipitation with mass spectrometry analysis:

  • Perform immunoprecipitation using anti-SPCC285.05 antibodies under both standard (30°C) and stress conditions (39°C)

  • Analyze the precipitated complexes by tandem mass spectrometry to identify interaction partners

  • This approach has successfully identified 294 proteins in GR-containing complexes in S. pombe under different conditions

• Proximity-based labeling:

  • Express SPCC285.05 fused to BioID or APEX2

  • Use antibodies to validate the proximity labeling results by co-immunoprecipitation

• Crosslinking immunoprecipitation (CLIP):

  • Apply in vivo crosslinking before cell lysis to capture transient interactions

  • Use anti-SPCC285.05 antibodies to pull down the crosslinked complexes

  • Reverse crosslinks and identify partners by western blotting or mass spectrometry

• Validation of interactions:

  • Confirm key interactions using reciprocal co-immunoprecipitation

  • Use yeast two-hybrid or split-GFP assays to verify direct interactions

  • Assess functional significance by analyzing phenotypes in deletion mutants of interaction partners

This multi-method approach provides robust identification of both stable and transient interaction partners of SPCC285.05.

What are the considerations for using anti-SPCC285.05 antibodies in immunofluorescence microscopy?

When using anti-SPCC285.05 antibodies for immunofluorescence microscopy in S. pombe, consider these critical parameters:

• Fixation method optimization:

  • For membrane proteins like SPCC285.05, mild fixation with 3-4% paraformaldehyde for 15-20 minutes often preserves epitope accessibility

  • Avoid methanol fixation which can distort membrane protein epitopes

  • Test both with and without 0.1-0.5% glutaraldehyde to determine optimal epitope preservation

• Cell wall digestion:

  • S. pombe requires enzymatic digestion with Zymolyase (1 mg/ml for 30-60 minutes) to create spheroplasts

  • Optimize digestion time to balance antibody accessibility with cellular structure preservation

• Permeabilization conditions:

  • For transmembrane proteins, test different detergents (0.1-0.5% Triton X-100, 0.05-0.1% SDS, or 0.5% saponin)

  • Saponin may be preferable as it preferentially permeabilizes membranes while preserving membrane protein localization

• Blocking and antibody dilution:

  • Use 2-5% BSA or 5-10% normal serum from the secondary antibody host species

  • Test antibody dilutions ranging from 1:100 to 1:1000

  • Include controls using SPCC285.05 knockout strains to confirm specificity

• Mounting and imaging parameters:

  • For transmembrane proteins, anti-fading agents without DAPI are preferable

  • Confocal microscopy with z-stacking is recommended to accurately capture membrane distribution

  • Consider co-staining with established membrane markers to confirm localization pattern

These optimizations will help ensure specific and accurate visualization of SPCC285.05 localization while minimizing background and preserving cellular architecture.

What steps should I take if my anti-SPCC285.05 antibody shows poor specificity in western blots?

If your anti-SPCC285.05 antibody demonstrates poor specificity in western blots, implement this systematic troubleshooting approach:

• Antigen retrieval optimization:

  • Test different sample preparation methods: standard SDS lysis vs. specialized membrane protein extraction buffers

  • Avoid boiling samples (use 37°C for 30 minutes instead) as membrane proteins can aggregate at high temperatures

  • Try reducing agent concentration adjustment (standard 100 mM DTT vs. 50 mM or 200 mM)

• Blocking optimization:

  • Compare different blocking agents: 5% non-fat milk vs. 3-5% BSA vs. commercial blocking reagents

  • For phospho-specific antibodies, always use BSA as milk contains phosphatases

  • Test longer blocking times (2-16 hours at 4°C) to reduce non-specific binding

• Antibody conditions refinement:

  • Titrate antibody concentration using dilutions from 1:250 to 1:5000

  • Test different incubation temperatures (4°C overnight vs. room temperature for 1-2 hours)

  • Add 0.05-0.1% Tween-20 to antibody dilution buffer to reduce background

• Validation and controls:

  • Run parallel western blots with SPCC285.05 knockout samples

  • Pre-absorb antibody with recombinant SPCC285.05 protein to confirm specificity

  • Consider peptide competition assays using the immunizing peptide

• Alternative detection strategies:

  • Try more sensitive detection methods (ECL Plus vs. standard ECL)

  • Consider using HRP-conjugated Protein A/G instead of species-specific secondary antibodies

  • For weak signals, implement signal enhancement systems or longer exposure times

This structured approach addresses the most common issues encountered with antibodies against membrane proteins and typically resolves specificity problems.

How can I assess and improve the thermal stability of anti-SPCC285.05 antibodies?

To assess and enhance thermal stability of anti-SPCC285.05 antibodies, implement these research-validated approaches:

• Thermal stability assessment:

  • Perform differential scanning fluorimetry (DSF) with SYPRO Orange to determine melting temperatures (Tm)

  • Conduct thermal challenge assays at various temperatures (37-70°C) for 10-60 minutes followed by antigen binding assessment

  • Implement a library-scale thermal challenge assay to screen multiple antibody variants simultaneously

• Stabilization through buffer optimization:

  • Test various buffer conditions in a thermal shift assay format:

    Buffer Component	Range to Test	Typical Optimal
    pH	5.0-8.0	6.0-7.0
    NaCl	0-500 mM	150 mM
    Stabilizers	Glycerol, sucrose, trehalose	5-10%
    Surfactants	Tween-20, Pluronic F-68	0.01-0.05%

• Protein engineering approaches:

  • Introduce stabilizing mutations based on computational design

  • Consider framework swapping with thermostable antibody frameworks

  • Implement structure-guided antibody design focused on CDR stabilization

• Selection-based approaches:

  • Utilize yeast display of antibody libraries combined with thermal challenge

  • Select thermostable variants that retain binding after heat shock at 60°C

  • This approach has yielded antibodies with 5-50 fold improved affinity and enhanced thermal stability

• Storage and handling recommendations:

  • Store purified antibodies in 50% glycerol/PBS at -20°C

  • Avoid repeated freeze-thaw cycles (aliquot before freezing)

  • Add stabilizing excipients (10 mM arginine, 5% sorbitol) for long-term storage

These strategies can significantly enhance antibody stability, extending shelf-life and improving performance across applications.

How can I develop bispecific antibodies incorporating anti-SPCC285.05 binding domains?

Developing bispecific antibodies incorporating anti-SPCC285.05 binding domains requires a systematic approach:

• Binding domain selection and optimization:

  • Select high-affinity anti-SPCC285.05 scFv domains with demonstrated stability

  • Engineer the selected scFvs to improve thermal stability through yeast display and thermal challenge (60°C) selection

  • Optimize affinity through directed evolution and high-throughput screening

• Format selection based on research goals:

  • For targeting membrane complexes: IgG-scFv format with anti-SPCC285.05 as the scFv domain

  • For detecting protein-protein interactions: Tandem scFv format

  • For therapeutic applications: Choose tetravalent formats with two binding sites for each target

• Modular design implementation:

  • Use flexible linkers (GGGGS)n between domains to maintain independent folding

  • Consider orientation screening (N- vs C-terminal fusion) to identify optimal configurations

  • Test multiple prototype configurations simultaneously to identify optimal architecture

• Expression and purification optimization:

  • Test mammalian (CHO, HEK293) and non-mammalian (yeast, insect) expression systems

  • Implement high-throughput micro-scale purification for rapid screening

  • Characterize biophysical properties including thermal stability, aggregation propensity, and binding kinetics

• Functional validation:

  • Confirm simultaneous binding to SPCC285.05 and the second target

  • Verify specificity using competitive binding assays

  • Assess biological activity in relevant model systems

This systematic approach has been successfully applied to developing tetravalent bispecific antibodies targeting multiple receptors simultaneously and can be adapted for SPCC285.05-targeting constructs .

What are the considerations for using SPCC285.05 antibodies in studying stress response pathways in yeast?

When investigating stress response pathways involving SPCC285.05 in yeast using antibodies, consider these advanced research parameters:

• Temperature-dependent interaction studies:

  • Compare SPCC285.05 protein interactions under normal (30°C) and stress conditions (39°C)

  • Use antibodies to immunoprecipitate SPCC285.05 complexes at different temperatures to identify stress-specific interaction partners

  • This approach has successfully identified 294 stress-responsive proteins in other yeast studies

• Stress granule association analysis:

  • Investigate whether SPCC285.05 localizes to stress granules under thermal stress

  • Co-immunoprecipitation with known stress granule components (eIF2, 40S ribosomal subunit, translation initiation factors)

  • Use fluorescence microscopy with anti-SPCC285.05 antibodies to track relocalization during stress response

• Signaling pathway interrogation:

  • Study the potential involvement of SPCC285.05 in stress-activated protein kinase (SAPK) pathways

  • Investigate interaction with Sty1 (S. pombe orthologue of mammalian p38/SAPK) and upstream kinases

  • Use phospho-specific antibodies to determine if SPCC285.05 is phosphorylated during stress response

• Comparative analysis with stress-protective systems:

  • Investigate potential interactions between SPCC285.05 and molecular chaperones like Hsp104

  • Determine if SPCC285.05 contributes to thermotolerance in a manner similar to or distinct from established stress response systems

  • Use knockout strains to assess functional interdependencies

• Evolutionary conservation analysis:

  • Compare SPCC285.05's role in stress response to nucleoside transporters in other organisms

  • Determine if antibodies against conserved epitopes cross-react with homologous proteins in related species

This comprehensive approach leverages antibodies as tools to elucidate SPCC285.05's potential role in stress response mechanisms, which has not been previously characterized.

How can I develop a quantitative assay to measure SPCC285.05 expression levels in different growth conditions?

Developing a quantitative assay for SPCC285.05 expression requires consideration of the protein's membrane localization and potential regulation under various conditions:

• Quantitative western blot optimization:

  • Develop a standard curve using recombinant SPCC285.05 protein at known concentrations

  • Implement consistent sample preparation methods optimized for membrane proteins

  • Use housekeeping proteins specific to membrane fractions (e.g., Na+/K+ ATPase) for normalization

  • Employ near-infrared fluorescent secondary antibodies for broader linear dynamic range

• ELISA development:

  • Design a sandwich ELISA using two non-competing anti-SPCC285.05 antibodies

  • For membrane proteins like SPCC285.05, include optimal detergent concentrations (0.1-0.5% DDM or CHAPS) in all buffers

  • Develop standard curves using recombinant protein in detergent-containing buffer

  • Validate assay parameters:

    Parameter	Target Specification
    Sensitivity	10-50 pg/ml
    Dynamic Range	2-3 log units
    Intra-assay CV	<10%
    Inter-assay CV	<15%
    Recovery	80-120%

• Flow cytometry approach:

  • Develop protocols for consistent spheroplast preparation

  • Optimize fixation and permeabilization for intracellular staining

  • Use fluorophore-conjugated anti-SPCC285.05 antibodies

  • Include calibration beads to convert fluorescence to molecules of equivalent soluble fluorophore (MESF)

• Mass spectrometry-based quantification:

  • Develop selected reaction monitoring (SRM) assays targeting unique peptides from SPCC285.05

  • Use anti-SPCC285.05 antibodies for immunoaffinity enrichment prior to MS analysis

  • Include isotopically labeled standard peptides for absolute quantification

  • This approach offers highest specificity and can distinguish between post-translational modifications

• Validation across conditions:

  • Test assay performance across diverse stress conditions (temperature, osmotic, oxidative)

  • Compare protein levels with mRNA expression (RT-qPCR) to identify post-transcriptional regulation

  • Assess assay robustness across different S. pombe strains and growth phases

This comprehensive approach provides researchers with multiple validated methods to quantitatively assess SPCC285.05 expression levels with high specificity and reproducibility.